Kither Biotech jobs and careers
Torino, Italy
About Kither Biotech
Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development of new drugs to treat chronic inflammatory diseases.In recent years Kither has focused its first line of activities on the development of a small peptide(KIT2014) developed internally for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and that currently has no cure. The KIT2014 peptide was assigned the Orphan Drug designation from the European Medicines Agency. The KIT2014 compound is currently undergoing the pre-clinical phase of clinical development.Kither’s product portfolio also includes a molecule (CL27), also developed internally, that is being developed for the treatment of Chronic Obstructive Pulmonary Diseases and Allergic Asthma. The company is about to start the pre-clinical phase of development of the CL27 molecule.
Founded in 2018 by Emilio Hirsch and Marco Kevin Malisani.
- Founded
- 2018
- Employees
- 1 to 10
- Total funding
- $24.1M
- Headquarters
- Torino
Leadership
The top of Kither Biotech's org chart, with how many people report into each leader.
Valentina Sala
Head of Scientific Affairs
1 report
Alessandra Ghigo
Co-founder and Shareholder
Carla Uslenghi
Chief Medical Officer
Emilio Hirsch
Founder
Svetlana Vashkel
Non-Executive Director
Dimitrios Goundis
Chief Executive Officer
Marco Kevin Malisani
Co-founder and Executive Director
Janki Bhatt
Research Associate I
Jobs at Kither Biotech
No open positions right now. Explore more companies on TheJobsMap.